Xponance’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.34M Sell
10,688
-3,624
-25% -$793K 0.02% 502
2025
Q1
$3.2M Sell
14,312
-390
-3% -$87.3K 0.03% 404
2024
Q4
$4.82M Sell
14,702
-2,056
-12% -$673K 0.04% 313
2024
Q3
$5.03M Buy
16,758
+2,667
+19% +$801K 0.05% 304
2024
Q2
$4.64M Sell
14,091
-2,962
-17% -$976K 0.05% 301
2024
Q1
$6.75M Buy
17,053
+483
+3% +$191K 0.07% 231
2023
Q4
$5.83M Sell
16,570
-829
-5% -$292K 0.07% 230
2023
Q3
$6.53M Buy
17,399
+297
+2% +$111K 0.09% 189
2023
Q2
$6.54M Buy
17,102
+204
+1% +$78K 0.09% 197
2023
Q1
$5.85M Sell
16,898
-373
-2% -$129K 0.09% 222
2022
Q4
$4.06M Buy
17,271
+2,248
+15% +$529K 0.07% 275
2022
Q3
$3.7M Buy
15,023
+1,049
+8% +$258K 0.07% 253
2022
Q2
$4.23M Buy
13,974
+1,300
+10% +$393K 0.08% 199
2022
Q1
$5.21M Sell
12,674
-7,725
-38% -$3.17M 0.09% 191
2021
Q4
$9.57M Sell
20,399
-7,113
-26% -$3.34M 0.15% 118
2021
Q3
$11.7M Sell
27,512
-419
-2% -$178K 0.22% 81
2021
Q2
$10M Buy
27,931
+17,122
+158% +$6.15M 0.18% 97
2021
Q1
$3.05M Buy
10,809
+2
+0% +$564 0.06% 239
2020
Q4
$3.06M Buy
10,807
+207
+2% +$58.7K 0.07% 239
2020
Q3
$2.91M Sell
10,600
-36
-0.3% -$9.9K 0.07% 219
2020
Q2
$2.42M Buy
+10,636
New +$2.42M 0.06% 237